A 12-week, Multicenter, Randomized, Double-blind, Double-dummy, 2-arm Parallel Group Study Comparing the Efficacy and Safety of Foster 100/6mg NEXThaler, 2 Inhalations b.i.d, Versus Foster 100/6mg pMDI, 2 Puffs b.i.d in Patients With Controlled Asthma
Phase of Trial: Phase III
Latest Information Update: 17 May 2019
Price : $35 *
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms FORTUNE
- Sponsors Chiesi Farmaceutici
- 15 May 2019 Planned End Date changed from 19 Mar 2019 to 31 Dec 2020.
- 15 May 2019 Planned primary completion date changed from 19 Mar 2019 to 24 Dec 2020.
- 06 Mar 2018 New trial record